Moderate riskFDA DrugClass II

Appco Pharma prazosin capsules recalled for nitrosamine impurity

Appco Pharma LLC is recalling specific lots of prazosin hydrochloride 5mg capsules because they contain higher-than-acceptable levels of a nitrosamine impurity (N-nitroso-prazosin). Nitrosamines are chemical contaminants that may increase health risks with long-term exposure. This is a manufacturing quality issue, not a safety defect in the drug itself.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if your prazosin bottle matches one of the recalled lots (2406255UC, 2406256UC, 2407313UC, 2408351UC, 2408352UC, or 2509311UC).
  2. Contact your pharmacist or doctor if you have a recalled lot—do not stop taking prazosin without guidance.
  3. Your pharmacist can provide a replacement from a non-recalled lot or help you switch medications if needed.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Prazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-068-11.
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 3 products — see all of them.

Details

Units affected
28,157 bottles- 100's count
Illnesses reported
None reported
Manufactured in
262 Old New Brunswick Rd Ste N, Piscataway, NJ, United States
Classification
Class II
Recall number
D-0421-2026

In the FDA's words

Description
Prazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-068-11. cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits. Lot:2406255UC, Exp.: 2026/MAY; 2406256UC, Exp.: 2026/JUL; 2407313UC Exp.: 2026/JUL; 2408351UC, Exp.: 2026/JUL; 2408352UC , Exp.: 2026/JUL; 2509311UC, Exp.: 2027/SEP. . Distribution: U.S.A. Nationwide Affected quantity: 28,157 bottles- 100's count
Hazard
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

3 products in this recall

The agency lists each product separately. Check every one you might have.

Related topics

OtherUnapproved drugsDrugsSold nationwideMore from FDA Drug